Javascript must be enabled to continue!
LncRNA Snhg1-driven self-reinforcing regulatory network promotes cardiomyocyte cytokinesis and improves cardiac function
View through CrossRef
AbstractMost of current cardiac regenerative approaches result in very limited cell division. Positive feedback loops are vital for cell division, but their role in CM regeneration remains unclear. We aimed to demonstrate that lncRNA Snhg1 formed a positive feedback loop with c-Myc to induce stable CM cytokinesis. We found that Snhg1 expression was increased in human and mouse fetal and myocardial infarction (MI) hearts, particularly in CMs. Snhg1 overexpression elicited stable CM proliferation and improved post-MI cardiac function. Antagonism of Snhg1 in neonatal mice inhibited CM proliferation and impaired cardiac repair after MI. Proliferative effect was confirmed using cardiac-specific transgenic mice. RNA pull-down assays showed that Snhg1 directly bound to PTEN and activated PI3K-Akt pathway, resulting in c-Myc activation. Chromatin immunoprecipitation experiments showed that Snhg1 expression was upregulated by c-Myc binding to the Snhg1 promoter region, indicating a positive feedback loop between c-Myc and Snhg1. In conclusion, c-Myc/Snhg1/PI3k-Akt positive feedback loop drove sustained activation of cell cycle re-entry and induced stable CM cytokinesis, and thus may be an attractive strategy for promoting heart regenerative response.Clinical PerspectivesMost of the current cardiac regenerative approaches result in very limited cell division and little new cardiomyocyte (CM) mass. Positive feedback loops are vital for cell division, but their role in CM regeneration remain unclear. Here, we identified the long noncoding RNA Snhg1 as a driver to induce stable CM division and improve cardiac function after myocardial infarction (MI) by forming a positive feedback loop to sustain PI3K-Akt signaling activation. This finding might provide a novel therapeutic of Snhg1 as a promising regenerative approach to improve the prognosis of patients with heart failure.
Cold Spring Harbor Laboratory
Title: LncRNA Snhg1-driven self-reinforcing regulatory network promotes cardiomyocyte cytokinesis and improves cardiac function
Description:
AbstractMost of current cardiac regenerative approaches result in very limited cell division.
Positive feedback loops are vital for cell division, but their role in CM regeneration remains unclear.
We aimed to demonstrate that lncRNA Snhg1 formed a positive feedback loop with c-Myc to induce stable CM cytokinesis.
We found that Snhg1 expression was increased in human and mouse fetal and myocardial infarction (MI) hearts, particularly in CMs.
Snhg1 overexpression elicited stable CM proliferation and improved post-MI cardiac function.
Antagonism of Snhg1 in neonatal mice inhibited CM proliferation and impaired cardiac repair after MI.
Proliferative effect was confirmed using cardiac-specific transgenic mice.
RNA pull-down assays showed that Snhg1 directly bound to PTEN and activated PI3K-Akt pathway, resulting in c-Myc activation.
Chromatin immunoprecipitation experiments showed that Snhg1 expression was upregulated by c-Myc binding to the Snhg1 promoter region, indicating a positive feedback loop between c-Myc and Snhg1.
In conclusion, c-Myc/Snhg1/PI3k-Akt positive feedback loop drove sustained activation of cell cycle re-entry and induced stable CM cytokinesis, and thus may be an attractive strategy for promoting heart regenerative response.
Clinical PerspectivesMost of the current cardiac regenerative approaches result in very limited cell division and little new cardiomyocyte (CM) mass.
Positive feedback loops are vital for cell division, but their role in CM regeneration remain unclear.
Here, we identified the long noncoding RNA Snhg1 as a driver to induce stable CM division and improve cardiac function after myocardial infarction (MI) by forming a positive feedback loop to sustain PI3K-Akt signaling activation.
This finding might provide a novel therapeutic of Snhg1 as a promising regenerative approach to improve the prognosis of patients with heart failure.
Related Results
Abstract 1544: The lncRNA SNHG1 modulates quiescence and chemoresistance of prostate cancer
Abstract 1544: The lncRNA SNHG1 modulates quiescence and chemoresistance of prostate cancer
Abstract
Prostate cancer dormancy and chemoresistance contributes to long term morbidity and mortality from this disease. The long non-coding RNA (lncRNA) SNHG1 is h...
Integrative Mapping of SNHG1 RNA–Chromatin Contacts onto the Cancer-Specific Super-Enhancer Landscape in HCT116 Colorectal Cancer Cells
Integrative Mapping of SNHG1 RNA–Chromatin Contacts onto the Cancer-Specific Super-Enhancer Landscape in HCT116 Colorectal Cancer Cells
Long non-coding RNAs (lncRNAs) interact with chromatin and recruit epigenetic complexes to specific genomic loci, yet their relationship with super-enhancers (SEs), key regulatory ...
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract
Global studies of the transcriptome reveal that approximately half of human transcriptional units (genes) encode solely non-protein-coding RNAs (ncRNAs), wh...
Human Papillomavirus 16 E6 Promotes Angiogenesis of Lung Cancer by SNHG1
Human Papillomavirus 16 E6 Promotes Angiogenesis of Lung Cancer by SNHG1
Abstract
Human papillomavirus (HPV) is a risk factor for lung cancer. However, the mechanisms underlying is not known. Long noncoding RNAs (lncRNAs) have been found to play...
Abstract P2029: The Role Of Runx1 In Cardiomyocyte Cell Cycle Activity And Its Impact On Cardiac Regeneration
Abstract P2029: The Role Of Runx1 In Cardiomyocyte Cell Cycle Activity And Its Impact On Cardiac Regeneration
Factors responsible for cardiomyocyte proliferation may serve as a potential therapeutic to stimulate endogenous myocardial regeneration following insult, such as ischemic injury. ...
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (LncRNA) as a biomarker and therapeutic agent for cancer
Long non-coding RNA (lncRNA) are transcripts of >200 nucleotides that do not translate into proteins. Once considered as a part of transcriptional noise, now with advanced genom...
Identification of Long Non‐Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis
Identification of Long Non‐Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis
Objective: To explore the feasibility and clinical application value of differentially expressed lncRNA in human peripheral blood mononuclear cell (PBMC) as a potential biomarker f...
GW24-e2217 AKAP150 anchored PKC to enhance cardiomyocyte damage in diabetes
GW24-e2217 AKAP150 anchored PKC to enhance cardiomyocyte damage in diabetes
Objectives
Cardiovascular disease is the main cause of death in patients with diabetes. It is reported that Protein kinase C signalling pathway plays a key role i...

